Nanobiotix S.A.
NBTX
$28.23
-$2.08-6.86%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 74.05% | 76.14% | -294.83% | -302.77% | 23.03% |
| Total Depreciation and Amortization | 7.04% | -1.57% | 7.12% | 9.28% | 4.88% |
| Total Amortization of Deferred Charges | -- | -- | 0.00% | 0.00% | -- |
| Total Other Non-Cash Items | -609.06% | -567.98% | 158.04% | 163.23% | -32.60% |
| Change in Net Operating Assets | -85.67% | -86.82% | -52.49% | -51.53% | 113.26% |
| Cash from Operations | -214.58% | -189.21% | -382.97% | -388.66% | 66.60% |
| Capital Expenditure | 67.67% | 70.27% | -6,948.15% | -7,166.67% | -49.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.25% | -5.00% | -467.39% | -479.57% | -168.18% |
| Cash from Investing | 65.85% | 68.61% | -1,955.08% | -1,984.17% | -51.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -21.90% | -21.90% | -12.06% | -12.06% | -8.66% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 44.83% | 44.83% | 96.04% | 96.04% | -50.37% |
| Cash from Financing | -12.40% | -3.33% | -105.02% | -105.12% | -22.79% |
| Foreign Exchange rate Adjustments | -1,364.94% | -1,263.09% | 252.81% | 255.56% | 335.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00% | 20.00% | -- |
| Net Change in Cash | -146.51% | -126.63% | -130.63% | -131.25% | 55.22% |